Skip to main content
BJS Open logoLink to BJS Open
. 2023 Aug 1;7(4):zrad057. doi: 10.1093/bjsopen/zrad057

Effects of exercise after oesophagectomy on body composition and adequacy of energy and protein intake: PERFECT multicentre randomized controlled trial

Anouk Hiensch 1,, Elles Steenhagen 2, Jonna K van Vulpen 3, Jelle P Ruurda 4, Grard A P Nieuwenhuijzen 5, Ewout A Kouwenhoven 6, Richard P R Groenendijk 7, Donald L van der Peet 8, Camiel Rosman 9, Bas P L Wijnhoven 10, Mark I van Berge Henegouwen 11,12, Hanneke W M van Laarhoven 13,14, Richard van Hillegersberg 15, Peter D Siersema 16, Anne M May 17
PMCID: PMC10392959  PMID: 37527034

Introduction

Patients with localized oesophageal cancer may experience long-lasting symptoms following cancer treatment (that is often neoadjuvant chemo(radio)therapy followed by oesophagectomy)1,2, resulting in suboptimal intake of nutrients in the first postoperative year3. This might cause persistent weight and muscle loss and a progressive decline in nutritional status4–9. Strategies to counteract weight and muscle loss involve exercise and nutritional interventions10,11. However, specific recommendations for nutritional interventions during oncological exercise programmes are lacking12.

In the randomized Physical ExeRcise Following Oesophageal Cancer Treatment (PERFECT) study, a 12-week supervised exercise programme was demonstrated to be safe and feasible after oesophagectomy and effective in terms of improved quality of life (QoL) (primary outcome), role functioning, and cardiorespiratory fitness13. As part of the secondary analysis of the PERFECT study, the aim is to assess whether or not participants in the PERFECT study meet their energy and protein requirements and investigate exercise effects on body composition, malnutrition risk, and energy expenditure. Getting more insight into this would be of great importance for optimal nutritional strategies during the recovery phase.

Methods

Setting and participants

The PERFECT study is a multicentre randomized controlled trial performed in nine Dutch hospitals between 2015 and 2019. The design of the PERFECT study has been published previously14. The trial was registered on 19 January 2015 in the Dutch Trial Register (NTR 5045) (https://trialsearch.who.int/Trial2.aspx? TrialID = NTR5045). See Text S1 for inclusion and exclusion criteria. The study was approved by the Medical Ethics Committee of the University Medical Center (UMC) Utrecht and the local Ethical Boards of participating hospitals.

After signing written informed consent and completing baseline measurements, participants were randomly allocated to a 12-week supervised exercise intervention (EX) or usual care group (UC).

Dietetic study

Patients included in the UMC Utrecht were asked to participate in optional dietetics measurements. During these measurements, resting energy expenditure (REE), body composition, and nutritional status were measured.

Additional informed consent was obtained before baseline testing and randomization.

Intervention

The exercise intervention consisted of a 12-week supervised, individualized, combined aerobic and resistance exercise programme, in addition to UC. Details of the exercise programme have been published elsewhere and are summarized in Text S114.

Outcome measures

Table 1 provides an overview of all outcome measures of the PERFECT study, which are of interest for the current secondary analysis. Detailed information about all outcome measures can be found in Text S1.

Table 1.

Outcome assessment in all PERFECT participants and in the dietetic subgroup

Outcome assessment All PERFECT participants Dietetic subgroup
Dietary intake
  • Energy intake

X X
  • Protein intake

X X
Anthropometry
  • Weight

X X
  • Height

X X
Body composition
  • Fat mass (kg), fat mass index (kg/m2)

  • Fat free mass (kg), fat free mass index (kg/m2)

X
X
Resting energy expenditure
  • Estimated (WHO-formula)

X X
  • Measured (indirect calorimetry)

X
  • Oxygen consumption (VO2), carbon dioxide production (VCO2), and respiratory quotient (RQ)

X
PG-SGA
  • Risk for malnutrition

X X
  • Nutritional status

X

PG-SGA, Patient Generated Subjective Global Assessment.

Statistical analysis

A paired samples t test was performed to assess adequacy of dietary intake. All outcomes were analysed as between-group differences in outcomes using intention-to-treat analysis of covariance (ANCOVA). Detailed information can be found in Text S1.

Results

Participants

In total, 79 of all 120 PERFECT participants were invited to participate in the optional dietetic measurements and 37 participants agreed. In the dietetic study, five participants were lost to follow-up (EX: three of 19, UC: two of 18) (Fig. S1).

Baseline and nutritional characteristics of all PERFECT participants and participants in the dietetic study are shown in Table S1 and Table S2 respectively.

All participants (n = 120)

Dietary intake

At baseline (3 (2–7) months postoesophagectomy (median, interquartile range (i.q.r.)), participants had a mean energy and protein intake of 2413 kcal/day (s.d. = 640) and 94 gram/day (s.d. = 28) respectively. No clinically relevant changes in energy and protein intake were observed in either group during the intervention period. Postintervention, energy and protein intake were comparable between groups (Table 2). At baseline, 63.2 per cent and 37.6 per cent of all participants had an adequate energy and protein intake respectively (Tables S3–S5). At 12 weeks these percentages were 66.0 per cent and 33.3 per cent respectively.

Table 2.

Effects of the PERFECT exercise intervention on weight, risk for malnutrition and dietary intake among all participants in the PERFECT study (n = 120) and effects of the PERFECT exercise intervention on weight, body composition, nutritional status, resting energy expenditure, and dietary intake in the dietetic subgroup (n = 37)

Baseline Baseline to 12 weeks (post-intervention)
Mean(s.d.) Within-group differences Between-group differences Effect size
Mean [95% c.i.] Mean [95% c.i.]
All PERFECT participants (n = 120)
Weight (kg) EX 76.1(12.5) −1.16 [−1.95, −0.37]* −1.19 [−2.48, 0.10] 0.09
UC 78.2(13.3) −0.63 [−1.41, 0.15] Reference
Risk for malnutrition EX 7.4(5.2) −1.88 [−3.21, −0.55]* −0.17 [−2.12, 1.79] 0.03
UC 7.4(5.1) −0.64 [−1.96, 0.68] Reference
Dietary intake
 Energy intake kcal/kg/day EX 32.5(8.9) 0.53 [0.20, 0.87]* 0.36 [−0.17, 0.89] 0.04
UC 31.1(8.3) 0.17 [−0.23, 0.56] Reference
 Protein intake gram/kg/day EX 1.27(0.37) 0.02 [−0.08, 0.11] 0.01 [−0.11, 0.13] 0.03
UC 1.20(0.36) 0.05 [−0.04, 0.14] Reference
Dietetic subgroup (n = 37)
Dietary intake
 Energy intake (kcal/kg/day) EX 33.1(10.1) 0.68 [−0.07, 1.42] 0.41 [−0.72, 1.54] 0.05
UC 29.2(8.0) 0.15 [−0.48, 0.78] Reference
 Protein intake (gram/kg/day) EX 1.3(0.37) −0.11 [−0.23, 0.01] −0.13 [−0.35, 0.09] 0.37
UC 1.1(0.34) 0.10 [−0.08, 0.29] Reference
 Protein intake (gram/kg FFM/day) EX 1.7(0.41) −0.18 [−0.33, −0.02]٭ −0.17 [−0.47, 0.13] 0.41
UC 1.5(0.43) 0.12 [−0.14, 0.38] Reference
Weight (kg) EX 73.5(13.0) −1.68 [−3.81, 0.45] −1.51 [−4.56, 1.54] 0.12
UC 78.0(12.2) −0.29 [−1.90, 1.32] Reference
Body composition
 FFMI (kg/m²) EX 18.2(2.1) −0.04 [−0.41, 0.33] −0.11 [−0.67, 0.45] 0.05
UC 18.2(2.1) 0.09 [−0.25, 0.43] Reference
 FMI (kg/m²) EX 6.2(1.9) −0.51 [−0.94, −0.09]* −0.36 [−0.91, 0.18] 0.20
UC 6.4(1.7) −0.20 [−0.61, 0.22] Reference
Resting energy expenditure
 REE measured (kcal/day) EX 1597(237) 66.19 [−2.95, 135.33] 76.46 [−31.92, 184.84] 0.30
UC 1777(268) −85.25 [−161.23, −9.27]* Reference
 REE measured (kcal/kg/day) EX 22.0(2.9) 1.38 [0.50, 2.26]* 1.62 [0.42, 2.81]٭ 0.62
UC 22.6(2.3) −0.96 [−1.95, 0.04] Reference
 REE measured (kcal/kg FFM/day) EX 28.5(2.9) 1.29 [0.14, 2.44]* 1.17 [−0.39, 2.74] Reference 0.39
UC 30.1(3.1) −1.64 [−3.22, −0.07]*
 RQ, measured REE EX 0.80(0.07) −0.03 [−0.07, −0.003]* −0.06 [−1.1, −0.01]٭ 1.10
UC 0.77(0.04) 0.05 [0.01, 0.09]* Reference
 VO2 (l/min), measured REE EX 232.05(35.71) 11.44 [0.90, 21.98]* 14.60 [−2.36, 31.56] 0.39
UC 260.17(40.04) −15.38 [−27.42, −3.34]* Reference
 VCO2 (l/min), measured REE EX 185.37(27.34) 1.31 [−7.59, 10.22] −5.13 [−18.44, 8.17] 0.18
UC 199.61(28.24) 0.88 [−8.43, 10.18] Reference
Nutritional status (PGSGA)
 Risk for malnutrition EX 8.6(4.7) −1.94 [−4.23, 0.35] −2.22 [−5.85, 1.41] 0.47
UC 6.1(4.7) 1.61 [−1.39, 4.61] Reference
 Nutritional status score EX 10.3(4.9) −2.56 [−5.05, −0.08]* −3.73 [−7.60, 0.15] 0.78
UC 7.3(4.7) 2.13 [−1.10, 5.36] Reference

c.i., confidence interval; ES, effect size; EX, exercise group; s.d., standard deviation; UC, usual care group; FFM, fat free mass; FFMI, fat free mass index; FMI, fat mass index; REE, resting energy expenditure; RQ, respiratory quotient (VCO2/VO2); VO2, oxygen consumption; VCO2, carbon dioxide production; PG−SGA, Patient-Generated Subjective Global Assessment. Effect sizes <0.2 indicate ‘no difference’, effect sizes of 0.2–0.5 indicate ‘small differences’, effect sizes of 0.5–0.8 indicate ‘medium differences’ and effect sizes ≥0.8 indicate ‘large differences’.

Weight and risk for malnutrition

EX had a non-significant lower weight at 12 weeks compared with UC (−1.19 kg, 95 per cent c.i. −2.48 to 0.10, ES = 0.09) (Table 2). Malnutrition risk declined within EX, but no significant difference was observed when compared with UC.

Dietetic subgroup (n = 37)

Dietary intake

Postintervention, no significant differences in energy and protein intake between EX and UC were observed (Table 2). EX had a lower protein intake per kg weight per day (−0.11 g per kg per day, 95 per cent c.i. −0.23 to 0.01) and per kg fat free mass (FFM) per day (−0.18 g per kg FFM per day, 95 per cent c.i. –0.33 to −0.02) post-intervention compared with baseline. Similarly, a decline in adequacy of protein intake in g/FFM was observed from baseline to 12 weeks in EX (from 57.9 per cent to 25.0 per cent) (Tables S5 and S6). An adequate energy intake at baseline and 12 weeks respectively, was found in 52.6 per cent and 43.8 per cent of EX and 58.8 per cent and 43.8 per cent of UC (Table S4).

Weight and body composition

Postintervention, the between-group difference in weight was −1.51 kg (95 per cent c.i. −4.56 to 1.54, ES = 0.12). This decline in weight was mainly due to a decreased fat mass (FM) index from baseline to 12 weeks in EX (−0.51, 95 per cent c.i. −0.94 to −0.09), whereas the FFM index remained stable over time (Table 2). No statistically significant between-group differences in FM indices were observed postintervention (−0.36, 95 per cent c.i. −0.91 to 0.18, ES = 0.20).

Measured resting energy expenditure

Postintervention, EX had a significantly higher measured REE (mREE) per kg weight (1.62 kcal/kg, 95 per cent c.i. 0.42 to 2.81, ES = 0.62), mREE per kg FFM (1.17 kcal/kg FFM, 95 per cent c.i. −0.39 to 2.74, ES = 0.39), measured oxygen consumption (VO2) (14.60 ml/min, 95 per cent c.i. −2.36 to 31.56, ES = 0.39), and a significantly lower respiratory quotient (RQ) (−0.06 ml/min, 95 per cent c.i. –1.1 to −0.01, ES = 1.10) compared with UC (Table 2).

Risk of malnutrition and nutritional status

Postintervention, risk of malnutrition tended to be lower for EX compared with UC (−2.22, 95 per cent c.i. −5.85 to 1.41, ES = 0.47). Similarly, postintervention nutritional status tended to be better for EX compared with UC (−3.73, 95 per cent c.i. −7.60 to 0.15, ES = 0.78) (Table 2).

Discussion

This study showed that the majority of patients after oesophagectomy do not meet estimated protein requirements, especially when increasing physical activity levels as part of an exercise programme. Only slightly more than half of all participants meet the estimated energy requirements. These numbers were even lower when energy intake was compared with daily energy requirements calculated using the mREE. Measurement of REE is recommended to personalize energy needs15.

Patients participating in the PERFECT exercise programme were observed to lose more weight compared with controls, which seemed to be mainly loss of FM. FFM, which is commonly used as a proxy for skeletal muscle mass, remained stable over time in the exercise group. Since the exercise programme included progressive resistance training, an increase in muscle mass was expected. This counterintuitive finding could potentially be explained by the decreased protein intake in the exercise group. These findings suggest the need for a structured nutritional intervention, in addition to an exercise programme, which likely will result in larger effects of the exercise programme16,17. This might be of even greater importance for patients receiving immunotherapy after surgery in order to be able to complete this treatment18.

Exercise had a positive effect on the risk of being malnourished, while energy and protein intake was inadequate and patients participating in the exercise programme lost weight. The questionnaire used to measure risk of malnutrition consists of four domains: weight, food intake, nutrition impact symptoms, and activities and function. The scores for these particular domains remained fairly stable over time and were not different between groups, except for the nutrition impact symptom domain (Table S2). This suggests that the PERFECT exercise programme reduces patients’ relevant symptoms, leading to improvements in the patients’ nutritional status13.

This study has several limitations. Only half of the PERFECT participants decided to participate in the dietetic study, hampering the generalizability of the findings. Secondary outcomes are reported here, for which the study was not powered. Due to self-selection, patients who participated in the dietetic study had a relatively higher risk of malnutrition at baseline (43.2 per cent) compared with all participants (32.5 per cent). Finally, no data were available regarding the number of consultations with a dietitian during the study period and the specific recommendations that were given during this encounter.

The present study shows that patients in the first year after oesophagectomy are at risk of a suboptimal energy and protein intake, especially when increasing physical activity levels as part of an exercise programme. The results suggest that exercise has a small positive effect on the risk of being malnourished, and weight loss was mainly loss of FM and not FFM. These findings highlight the need for specific nutritional recommendations during oncological exercise programmes.

Supplementary Material

zrad057_Supplementary_Data

Acknowledgements

We would like to thank all participants and all professional staff at UMC Utrecht, Utrecht; Hospital Group Twente (ZGT), Almelo; Catharina Hospital, Eindhoven; St. Antonius Hospital, Nieuwegein; Amsterdam UMC, Amsterdam (formerly Amsterdam VU Medical Center and Academic Medical Center Amsterdam); IJsselland Hospital, Capelle aan den IJssel; Radboud University Medical Center, Nijmegen; Erasmus University Medical Center, Rotterdam for their invaluable participation in this trial. Anouk Hiensch and Elles Steenhagen are joint first authors.

Contributor Information

Anouk Hiensch, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Elles Steenhagen, Department of Dietetics, University Medical Center Utrecht, Utrecht, The Netherlands.

Jonna K van Vulpen, Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.

Jelle P Ruurda, Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Grard A P Nieuwenhuijzen, Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.

Ewout A Kouwenhoven, Department of Surgery, ZGT Hospital, Almelo, The Netherlands.

Richard P R Groenendijk, Department of Surgery, IJsselland Hospital, Capelle a/d IJssel, The Netherlands.

Donald L van der Peet, Department of Surgery, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.

Camiel Rosman, Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.

Bas P L Wijnhoven, Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.

Mark I van Berge Henegouwen, Department of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.

Hanneke W M van Laarhoven, Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands; Department of Medical Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.

Richard van Hillegersberg, Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.

Peter D Siersema, Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Anne M May, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Funding

The PERFECT study was funded by the World Cancer Research Fund The Netherlands (WCRF NL, project number 2013/997). They had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.

Disclosure

The authors declare no conflicts of interest.

Supplementary material

Supplementary material is available at BJS Open online.

Data availability

Data supporting the findings are available from the corresponding author upon reasonable request.

Author contributions

Anouk Hiensch (Data curation, Formal analysis, Investigation, Methodology, Project administration, Writing—original draft, Writing—review & editing), Elles Steenhagen (Conceptualization, Formal analysis, Investigation, Resources, Writing—original draft, Writing—review & editing), Jonna van Vulpen (Investigation, Methodology, Project administration, Supervision, Writing—review & editing), Jelle Ruurda (Data curation, Investigation, Resources, Writing—review & editing), Grard Nieuwenhuijzen (Data curation, Investigation, Resources, Writing—review & editing), Ewout Kouwenhoven (Data curation, Investigation, Resources, Writing—review & editing), Richard Groenendijk (Data curation, Investigation, Resources, Writing—review & editing), Donald van der Peet (Data curation, Investigation, Resources, Writing—review & editing), Camiel Rosman (Data curation, Investigation, Resources, Writing—review & editing), Bas Wijnhoven (Data curation, Investigation, Resources, Writing—review & editing), Mark van Berge Henegouwen (Data curation, Investigation, Resources, Writing—review & editing), Hanneke van Laarhoven (Data curation, Investigation, Resources, Writing—review & editing), Richard Van Hillegersberg (Data curation, Investigation, Resources, Writing—review & editing), Peter Siersema (Conceptualization, Data curation, Funding acquisition, Investigation, Resources, Writing—review & editing), and Anne M. May (Conceptualization, Funding acquisition, Investigation, Methodology, Supervision, Writing—review & editing).

References

  • 1. Schandl A, Johar A, Anandavadivelan P, Vikström K, Mälberg K, Lagergren P. Patient-reported outcomes 1 year after oesophageal cancer surgery. Acta Oncol (Madr) 2020;59:613–619 [DOI] [PubMed] [Google Scholar]
  • 2. Gottlieb-Vedi E, Kauppila JH, Malietzis G, Nilsson M, Markar SR, Lagergren J. Long-term survival in esophageal cancer after minimally invasive compared to open esophagectomy: a systematic review and meta-analysis. Ann Surg 2019;270:1005–1017 [DOI] [PubMed] [Google Scholar]
  • 3. Baker M, Halliday V, Williams RN, Bowrey DJ. A systematic review of the nutritional consequences of esophagectomy. Clin Nutr 2016;35:987–994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Martin L, Lagergren P. Risk factors for weight loss among patients surviving 5 years after esophageal cancer surgery. Ann Surg Oncol 2015;22:610–616 [DOI] [PubMed] [Google Scholar]
  • 5. Martin L, Lagergren P. Long-term weight change after oesophageal cancer surgery. Br J Surg 2009;96:1308–1314 [DOI] [PubMed] [Google Scholar]
  • 6. Greene CL, DeMeester SR, Worrell SG, Oh DS, Hagen JA, DeMeester TR. Alimentary satisfaction, gastrointestinal symptoms, and quality of life 10 or more years after esophagectomy with gastric pull-up. J Thorac Cardiovasc Surg 2014;147:909–914 [DOI] [PubMed] [Google Scholar]
  • 7. Wobith M, Weimann A. Oral nutritional supplements and enteral nutrition in patients with gastrointestinal surgery. Nutrients 2021;13:2655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Elliott JA, Doyle SL, Murphy CF, King S, Guinan EM, Beddy Pet al. Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg 2017;266:822–830 [DOI] [PubMed] [Google Scholar]
  • 9. Boshier PR, Klevebro F, Jenq W, Puccetti F, Muthuswamy K, Hanna GBet al. Long-term variation in skeletal muscle and adiposity in patients undergoing esophagectomy. Dis Esophagus 2021;34:doab016. doi: 10.1093/dote/doab016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Muscaritoli M, Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz Het al. ESPEN Practical guideline: clinical nutrition in cancer. Clin Nutr 2021;40:2898–2913 [DOI] [PubMed] [Google Scholar]
  • 11. Landi F, Camprubi-Robles M, Bear DE, Cederholm T, Malafarina V, Welch AAet al. Muscle loss: the new malnutrition challenge in clinical practice. Clin Nutr 2019;38:2113–2120 [DOI] [PubMed] [Google Scholar]
  • 12. Stout NL, Santa Mina D, Lyons KD, Robb K, Silver JK. A systematic review of rehabilitation and exercise recommendations in oncology guidelines. CA Cancer J Clin 2021;71:149–175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. van Vulpen JK, Hiensch AE, van Hillegersberg R, Ruurda JP, Backx FJ, Nieuwenhuijzen GAet al. Supervised exercise after oesophageal cancer surgery: the PERFECT multicentre randomized clinical trial. Br J Surg 2021;108:786–796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. van Vulpen JK, Siersema PD, van Hillegersberg R, Nieuwenhuijzen GA, Kouwenhoven EA, Groenendijk RPet al. Physical ExeRcise following esophageal cancer treatment (PERFECT) study: design of a randomized controlled trial. BMC Cancer 2017;17:1–9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Bendavid I, Lobo DN, Barazzoni R, Cederholm T, Coëffier M, de van der Schueren Met al. The centenary of the Harris-Benedict equations: how to assess energy requirements best? Recommendations from the ESPEN expert group. Clin Nutr 2021;40:690–701 [DOI] [PubMed] [Google Scholar]
  • 16. Rogeri PS, Zanella RJ, Martins GL, Garcia MD, Leite G, Lugaresi Ret al. Strategies to prevent sarcopenia in the aging process: role of protein intake and exercise. Nutrients 2021;14:52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Deutz NEP, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal Aet al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin Nutr 2014;33:929–936 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen Get al. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med 2021;384:1191–1203 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

zrad057_Supplementary_Data

Data Availability Statement

Data supporting the findings are available from the corresponding author upon reasonable request.


Articles from BJS Open are provided here courtesy of Oxford University Press

RESOURCES